Login
Super Investors BNY Mellon Small/Mid Cap Growth Fund

BNY Mellon Small/Mid Cap Growth Fund

Bny Mellon Investment Funds I · net assets $868M · 76 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 97.9% · STIV: 2.1%

Financial position

Total assets
$872M
Total liabilities
$4.75M
Net assets
$868M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $11.4M $3.55M $3.21M
Reinvestment $0 $0 $0
Redemptions $24.6M $29.1M $29.7M
Net realized gain (non-derivative) $3.74M $36.2M $29.1M
Net unrealized appreciation (non-derivative) $75.3M $-22.5M $49.5M

The three months of the reporting period, as filed; month 3 ends June 30, 2026.

Filing details

Registrant
Bny Mellon Investment Funds I
Registrant CIK
799295
Registrant LEI
5493000M3XIJVKIWWS65
Series
BNY Mellon Small/Mid Cap Growth Fund
Series ID
S000011499
Series LEI
549300DP427BBILWFN87
SEC file number
811-04813
Address
240 Greenwich Street, New York, US-NY, 10286, US
Phone
212-922-6400
Form
NPORT-P
Filed
August 21, 2026
Report period ends
September 30, 2026
Report month ends
June 30, 2026
Accession number
000094040026032815
Holding Value % of net assets
Repligen Corp EC $29.9M 3.45%
Baldwin Insurance Group Inc (the) EC $28M 3.23%
Guardant Health Inc EC $27.7M 3.20%
Construction Partners Inc EC $27.5M 3.17%
Casey's General Stores Inc EC $25.3M 2.91%
Bel Fuse Inc EC $25.1M 2.89%
Regal Rexnord Corp EC $24.1M 2.78%
Wingstop Inc EC $22.9M 2.64%
Curtiss-wright Corp EC $22.9M 2.63%
Herc Holdings Inc EC $22.4M 2.58%
Mks Inc EC $20.1M 2.31%
Brightspring Health Services Inc EC $19.9M 2.30%
Alignment Healthcare Inc EC $19.9M 2.29%
Bio-techne Corp EC $19.3M 2.23%
Flowserve Corp EC $19.1M 2.20%
Entegris Inc EC $18.8M 2.17%
Privia Health Group Inc EC $18.2M 2.09%
Timken Company (the) EC $17.6M 2.03%
First Watch Restaurant Group Inc EC $17.5M 2.02%
Sensata Technologies Holding PLC EC $17M 1.96%
Patrick Industries Inc EC $16.7M 1.92%
Ametek Inc EC $15.9M 1.84%
Qnity Electronics Inc EC $15.6M 1.80%
Standex International Corp EC $15.6M 1.79%
Dreyfus Institutional Preferred Money Market Funds STIV $14.5M 1.67%
Onto Innovation Inc EC $14.1M 1.62%
Esab Corp EC $13.6M 1.57%
Macom Technology Solutions Holdings Inc EC $13.4M 1.54%
Mirum Pharmaceuticals Inc EC $12.8M 1.47%
Suncrete Inc EC $12.1M 1.39%
Carlisle Companies Inc EC $12M 1.39%
Brunswick Corp EC $11.4M 1.32%
Dynatrace Inc EC $11.2M 1.29%
Black Rock Coffee Bar Inc EC $11M 1.26%
Nutanix Inc EC $10.5M 1.21%
Karman Holdings Inc EC $10.4M 1.20%
Yeti Holdings Inc EC $10.3M 1.18%
Ascendis Pharma A/s EC $10.2M 1.18%
Oceaneering International Inc EC $9.36M 1.08%
Rocket Companies Inc EC $9.27M 1.07%
Definium Therapeutics Inc EC $9.11M 1.05%
Loar Holdings Inc EC $8.65M 1.00%
Ryan Specialty Holdings Inc EC $8.53M 0.98%
Rh Inc EC $8.36M 0.96%
Knight-swift Transportation Holdings Inc EC $8.19M 0.94%
Madrigal Pharmaceuticals Inc EC $7.82M 0.90%
Lumen Technologies Inc EC $7.71M 0.89%
Ceribell Inc EC $7.6M 0.88%
Datadog Inc EC $7.06M 0.81%
Weatherford International PLC EC $5.88M 0.68%
Transocean Ltd EC $5.78M 0.67%
Rhythm Pharmaceuticals Inc EC $5.7M 0.66%
Atlassian Corp EC $5.55M 0.64%
Newamsterdam Pharma Company Nv EC $5.51M 0.64%
Fundbox EC $5.44M 0.63%
Cytokinetics Inc EC $5.31M 0.61%
Xenon Pharmaceuticals Inc EC $5.04M 0.58%
Locus Robotics EC $4.98M 0.57%
Rambus Inc EC $4.96M 0.57%
Dianthus Therapeutics Inc EC $4.85M 0.56%

Showing top 60 of 76 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support